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a b s t r a c t
Despite a signiﬁcant progress in prevention, treatment and management in the past
decades, stroke remains the most common disabling chronic condition in adult population.
It may be a source of serious temporary or permanent consequences. These consequences
should be recognised and measured for deﬁning and implementation of remedial inter-
ventions and for optimum utilisation of health care resources.
The aim of this work was to present sequels of stroke, taking into account objective and
subjective indices, as documented in the recent literature of the subject. Selected data on
mortality and survival following stroke were presented, the up-to-date literature was
reviewed and register-based prospective studies were presented on quality of life (QoL)
in post-stroke patients. Systematic reviews and meta-analyses of randomised controlled
trials (RCTs) were summed up, related to efﬁcacy of interventions aimed at improving QoL of
the patients. Moreover, the studies were reviewed on burden and QoL experienced by
caregivers of post-stroke patients and results were summed up of RCT synthesis aimed
at reducing the burden and at improving QoL in the caregivers.
The analysed studies indicated that stroke exerts a long-term, negative effect on patients'
QoL, promoting a decrease in this measure and burdening a signiﬁcant proportion of the
family caregivers. The applied till now different interventions and programmes targeted at
the patients and at their carers analysed in RCTs showed no or modest effects on improving
of QoL or reducing the caregiver's burden.
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Worldwide, the absolute number of people with a ﬁrst-ever
stroke increased by 68% in the last decades. Also the number of
people who had survived the stroke incidence has increased by
84%. If this trend persists in the year of 2030, 70 million stroke
survivors will live in the world [1]. A signiﬁcant proportion of
individuals surviving strokes can expect to face severe health
consequences and varying forms of limitations ranging from a
shortened life span trough temporal or permanent neurologi-
cal and functional impairments, to limitations in role fulﬁl-
ment and social participation. Recognition and measurement
of these consequences are important both from the theoretical
and practical point of view. Especially it may be useful for
deﬁning and implementation of preventive, remedial and
supportive interventions as well as for optimum allocation of
health care resources.
The purpose of this paper was to present multi-dimensional
sequelae of stroke, taking into account objective and subjective
indices, in the light of recent literature of the subject.
2. Sequelae of stroke in the light of objective
indices
Traditionally, consequences of stroke and treatment out-
comes were evaluated mainly using mortality rates, survival
coefﬁcients and indices of neurological or functional deﬁcits.
In the last decades stroke mortality rates have declined in
several countries, predominantly as an effect of primary and
secondary prevention, partly as a result of improved acute
stroke care and management. The recently published epide-
miological data indicate that between 1990 and 2010 stroke
mortality rates fell signiﬁcantly, on the average by 25%/100 000
globally [1]. In Poland with the unchanged incidence rate, 30
day mortality in ﬁrst-ever stroke decreased from 43% in 1991/
1992 to 14.9% in 2005 and one-year mortality – from 59.7% to
33.1% [2]. These data correspond to indices of survival,
according to which one year after stroke 64% patients remain
alive, with 43% after 5 years and 24% after 10 years [3].
Despite the proven efﬁcacy of rehabilitation, indices linked
to the post-stroke disability have persisted at a similar level for
many years [4]. The functional limitations, usually measured
using Barthel Index or Rankin Scale affect around 60% of the
patients, with the mean of more than ten to 25–30% patients
requiring assistance of other person [5,6]. In general popula-
tion matched for age and co-morbidities this proportion
ranges from 5% to 14.5% [6]. Considering types of self-care
activities the most pronounced need for care compared with
controls pertains transfers in the bathroom [Odds Ratio (OR)
= 5.0], dressing (OR = 4.7) and walking out-doors (OR = 5.8) [7].
The number of persons who require care decreases with
duration of the post-stroke time. Shortly after stroke a severe
or moderate disability can be noted in around 45% of patients,
10 years later in around 11% of patients [3]. It should be
mentioned, however, that 10 years after stroke 1 person
survives per every 5 affected individuals, on average [8].
Nevertheless, the absolute number of patients who require
help in daily life activities will continue to rise. This prognosisreﬂects the current facts and demographic trends pointing to
senescence of population, and is thought to be the result of the
high risk of a recurrent stroke and the linked to it new
disability as well as the aforementioned signiﬁcant reduction
in early post-stroke mortality [9].
3. Sequels of stroke in the light of subjective
indices
3.1. Quality of life in post-stroke patients
Beginning at 1990s the traditional, objective indices of stroke
consequences and the treatment outcomes have begun to be
supplemented by subjective indicators, presenting a patient's
perspective and deﬁned as the Patient Reported Outcome
(PRO). Among these indices the principal place takes QoL. Its
evaluation reﬂects the result of patient's coping with the
disease in various domains of life, perception of symptoms,
effects of adjustment or transgressing limitations induced by
the illness. The processes cause that the subjective evaluation
may signiﬁcantly differ from the objective one. It was shown
that as many as 40% of patients after stroke, participating in
randomised clinical trials (RCTs) and manifesting good
outcome according to objective indices, suffer from poor
QoL [10].
From the beginning, studies on QoL, related to the
evaluation of a natural course of diseases and/or treatment
outcomes were associated with considerations pertaining a
deﬁnition of QoL [11]. Several theoretical concepts appeared
and subsequently, attempts of their classiﬁcation. In 2011 the
Cochrane Collaboration presented and recommended three
main categories of QoL used in clinical trials which took into
account: (1) health-related quality of life (HRQOL) covering
those aspects of life which undergo signiﬁcant inﬂuence of
physical and mental health, (2) quality of life per se including
all aspects of life, for example, how an individual lives, where
he/she lives and how he/she enjoys in life, (3) quality of life as a
subjective bodily and emotional wellbeing [12].
Similar to the problem of deﬁnition, following a variability
period, a group of tools was deﬁned for evaluation of QoL after
stroke, currently in use by most of investigators [13,14]. The
tools encompass non-speciﬁc scales: SF-36, SF-12 and Euro-
QoL-5D, as well as speciﬁc scales: Stroke Impact Scale (SIS),
Stroke-Speciﬁc Quality of Life Scale (SS-QoL) and Stroke
Adapted Sickness Impact Proﬁle (SA SIP-30) [15]. For some of
the tools, including EuroQoL-5D and SF-36, Health Utility
Scores (HUS) were worked out which deﬁne the number of
years in life, with quality adjusted life years (QALY), for which
the scope ranges from HUS = 1 (perfect health), trough HUS = 0
(a condition equivalent to being dead according to healthy
people) to HUS < 0 (condition that healthy people consider
worse than being dead) [16].
First studies on QoL after stroke were mainly cross-
sectional. There were few prospective observations but they
covered a short period of time (few months to two years) and
included relatively small samples [17,18]. These studies
showed that stroke causes decrease in QOL and impairs most
aspects of patients' functioning. Stroke severity, post-stroke
disability and depression, female gender, advanced age and
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determinants of poor life quality [19]. Publications of that
period frequently postulated a need for long-term studies,
possibly repeated in time, so that QoL could be monitored at all
stages of recovery and predictive factors could be veriﬁed from
a longer perspective of time [17].
In response to that, in 2000s studies began to appear, which
presented results of long term research, conducted mainly on
the basis of stroke registers, including investigations of ‘‘real-
time’’ type, i.e. covering multi-year observation of the patients,
beginning at their ﬁrst stroke through the post-stroke years of
life. The studies encompassed or encompass (in cases of
continued projects) large groups of few hundred or even few
thousand patients. Also, more numerous results of multi-
centre RCTs began to appear in which QoL has been an
important end-point in the evaluation of clinical efﬁcacy of
treatment, rehabilitation or stroke care management [20]. In
2007 an International Stroke Trials Archive (VISTA) was
formed which made available for the authors rough, anony-
mous data of completed RCTs for novel or further detailed
exploration, including analysis of life quality [21].
One of the most important longitudinal studies involving
QoL assessment is South London Stroke Register (SLSR),
targeted at epidemiology, natural course and sequels of stroke,
documenting all new ﬁrst-ever stroke cases in the deﬁned
geographical region beginning at 1995. In the study QoL has
been evaluated using SF-12. The patients have been examined
in months 3rd and 12th after the stroke onset and, subse-
quently, every year in consecutive post-stroke life [3]. The till
now 17-year history demonstrated that QoL within its physical
aspects was more or less stable with tendency for signiﬁcant
deterioration in the recent three years of observation. In
mental domains the results were similar although a more
pronounced ﬂuctuation in time was noted. In both domains
patients' QoL was lower (37 and 46 pts, respectively) than in a
matched normal population (50 pts., SD = 10) [22].
Another prospective investigation is The Reasons for
Geographic and Racial Differences in Stroke (REgards), the
ongoing study conducted in USA, focused on incidence and
analysis of risk factors for stroke and coronary heart disease
among 45-year old or older individuals, randomly selected from
American population in the years of 2003–2007. An ancillary
project to the REgards is Caring for Adults Recovering from the
Effects of Stroke (CARES). This study examines the long-term
psychosocial impact of stroke on a subgroup of stroke survivors
registered in REgards and on matched stroke-free controls.
Furthermore the CARES study allows to compare QOL from the
pre-stroke to that of post-stroke period. Similarly to SLSR, QoL
has been evaluated using SF-12, with the norm-based score,
setting for the general population mean to 50 and the SD to 10. It
was shown that QoL in the patients evaluated 9–12 months after
the acute hospitalisation deteriorated signiﬁcantly both in the
physical and mental domains, as compared to pre-stroke period
and it amounted, respectively, to 46.5 vs. 40.3 and 54.8 vs. 53.4
[23].
The subsequent large prospective investigation is the New
Zealand stroke register, entitled the Auckland Regional
Community Stroke Study (ARCOS), conducted till now in four
consecutive population-based researches covering the years of
1981–1982 (ARCOS I), 1991–1992 (ARCOS II), 2002–2003 (ARCOSIII) and 2010–2015 (ARCOS IV). ARCOS studies are related to
epidemiology, stroke outcome and burden in patients, their
family caregivers and society. Quality of life of stroke survivors
has been evaluated by SF-36. It was found that QoL of the
patients registered in the ARCOS over a period 1991–1992,
evaluated 6 years after the stroke onset, deteriorated signiﬁ-
cantly in all eight subscales of SF-36, as compared to the
controls matched for age and sex. In the patients the SF-36
scores ranged from 47 to 84, while in the control group from 62
to 93 [7]. In turn, QoL of the patients registered in the ARCOS
study of 1981–1982, examined 21 years later did not differ from
the age and sex standardised population norms. However, it
should be added that out of 626 patients included, after 21
years only 54 individuals remained alive, and these very long
survivors at the inclusion to the study were signiﬁcantly
younger and their post-stroke neurological deﬁcit had been
less pronounced as compared to those who died earlier [8].
Apart from quantitative evaluations, the ARCOS IV study has
included also qualitative analyses, based on in-depth semi-
structured interviews performed at 6, 12, 24 and 36 months
after stroke. The authors intend to explore issues related to,
i.e., perceived impact of stroke, psychological adaptation
changes over time, coping strategies applied in life after
stroke. The results should soon be available [24].
Next important investigation is the North East Melbourne
Stroke Incidence Study (NEMESIS), aimed at evaluation of
epidemiological indices in the years of 1998–1999 in north-
eastern region of Melbourne and at a long-term evaluation of
stroke sequels in persons registered at the time. Health–related
QoL was evaluated using health utility score (HUS) developed for
the Assessment of Quality of Life Instrument scale (AQoL) [25].
The HUS was found to remain at a similar level at 2, 5, and 7
years after stroke (HUS = 0.47; 0.50; 0.51, respectively) and it was
signiﬁcantly lower than in general population of 70–75-year old
individuals (HUS = 0.75). A very low life quality (HUS ≤ 0.1) was
experienced by 25% of patients at 2 years since stroke, by 20%
after 5 years and 23% after 7 years. For comparison, in general
population of a similar age less than 3% of people were found to
have AQoL score ≤0.1[26]. Extremely low quality of life that may
be deemed worse than death (HUS < 0) was expressed by 5.8% of
patients at 7 years post- stroke [26–28]. The data were conﬁrmed
in the other recent assessment, performed within the Efﬁcacy of
Nitric Oxide in Stroke Trial, ENOS, with participation of 2569
patients, covering the ﬁrst three post-stroke months: HUS < 0
was noted in 12.5% patients [29].
Summing up the above presented results of prospective
studies of recent years, it can be said that stroke entails long-
term deterioration of health related QoL, both as compared to
pre-stroke period and to general population norms. Unfavour-
able patient-reported outcome is relatively common even
several years after stroke. This points to the need for
systematic evaluation of the stroke survivors and for a
systemic medical and social care not only in the early post-
stroke period but also for many years thereafter.
3.2. Effectiveness of interventions on improving health-
related quality of life following stroke
Among independent variables which determine quality of life
in stroke survivors one can distinguish unmodiﬁable and
Table 1 – Systematic reviews and meta-analyses evaluating effectiveness of various interventions on health related quality
of life in stroke survivors published between 2011 and 2014.
Authors, date RCT studiesa Intervention Results HRQoL measure
1. De Chen et al., 2011 [30] Metaanalysis
9 studies
Exercises Total effect size Hedges' g 0.32; 95%
CI, 0.12–0.51.
SF-36, SF-12, SIS
2. Graven et al., 2011 [31] Systematic review
9 studies
Insufﬁcient evidence according BES
(<50% studies achieved statistical
signiﬁcance)
SA SIP-30, SIP,
AQoL, other
3. Graven et al., 2011 [31] Systematic reviews
3 studies
Leisure therapy Moderate evidence according BES SA SIP-30, SIP, NHP
4. Dorstyn et al., 2014 [32] 4 studies Statistically and clinically signiﬁ-
cant effect
1 study
SF-36, GWB
5. Lennon et al., 2013 [33] Systematic reviews
6 studies
Self management
programmes
Signiﬁcant results in favour of the
self-management groups
4 studies
SSQoL, SF-36
SA SIP-30, SIS
6. Graven et al., 2011 [31] 2 studies Insufﬁcient evidence according BES
7. Graven et al., 2011 [31] Systematic review
7 studies
Comprehensive,
multidisciplinary
outpatient or
in-home rehabilitation
Strong evidence according BES SF-36, EuroQoL-5D,
VAS, SIP, NHP
8. Fens et al., 2013 [34] Systematic review
8 studies
Multidisciplinary
inpatient or
community care
Signiﬁcant favourable effects
2 studies
SA SIP-30, SF-36,
EuroQoL-5D,
SSQoL, SIP
9. Graven et al., 2011 [31] Systematic review
5 studies
Gait and balance
rehabilitation
Insufﬁcient evidence SA-SIP 30, NHP, SIS
10. Graven et al., 2011 [31] Systematic review
1 study
Information provision Insufﬁcient evidence SF-36
11. Peiris et al., 2011 [35] Metaanalysis
4 studies
Extra physical
therapy in acute
or rehabilitation settings
SMD: 0.48; 95% CI, 0.29–0.68. SF-36, Euro-QoL
12. Price et al., 2011 [37] Systematic review
1 study
Antidepressive
pharmacotherapy
Non-signiﬁcant difference treat-
ment group vs. placebo
SFE
Abbreviations: AQoL – Assessment of Quality of Life Instrument; GWB – General Well Being Scale; NHP – Nottingham Health Proﬁle; SIS – Stroke
Impact Scale; SIP – Stroke Impact Proﬁle; SA SIP – Stroke Adapted Sickness Impact Proﬁle; SSQoL – Stroke Speciﬁc Quality of life Scale; VAS –
Visual Analogue Scale; CI – Conﬁdence Interval; BES – Best Evidence Synthesis; SMD – Standardise Mean Difference.
a Only data on quality of life have been extracted from the reviews.
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mented in short-term and long-term observational studies,
include deﬁcit in functional ability, depression and anxiety
and lack of social support [19,26,28]. Therefore, it has been
postulated that treatment, rehabilitation and other therapeu-
tic interventions should be targeted just at the factors [28].
Efﬁcacy of speciﬁc methods or organisational solutions, in line
with contemporary standards of clinical practice, should be
veriﬁed in controlled, possibly randomised investigations. In
recent years such RCTs have become increasingly numerous,
as proven by increasingly frequent in the literature syntheses
of studies, systematic reviews and meta-analyses [30–35].
Summary of the systematic reviews covering recent 4 years
presented in Table 1, indicates that most of the studies were
focused on the evaluation of efﬁcacy various rehabilitation,
supportive and activating programmes. A proportion of the
programmes, mainly those with complex and multicompo-
nent interventions, appeared to have a modest positive effect
on patients' QoL although the authors' conclusion about the
effectiveness of similar programmes were not always consis-
tent because of different measures of efﬁcacy used by differentauthors (Table 1: numbers 1, 3, 4, 5, 7, 8, 11). Among the
approaches which seems to be beneﬁcial are comprehensive
rehabilitation, multidisciplinary care and leisure therapy.
As can be seen in Table 1, a proportion of the programmes,
particularly those of a narrow scope of intervention, failed to
gain support in scientiﬁc evidence (Table 1: numbers 2, 6, 9, 10).
The number of pooled analyses, which would allow to draw
unequivocal conclusions or practical recommendations, still
remains insufﬁcient. Therefore, the need is accentuated for
further studies, in particular such which are targeted directly
at QoL domains, rather than assuming that QoL will
automatically change when relatively narrow functions or
basic activities are improved [31].
It is worth noticing that even tough depression and anxiety
have been repeatedly documented as signiﬁcant determi-
nants of poor post-stroke QoL [36], until now few RCTs were
conducted related to anti-depressive or anti-anxiety treat-
ment or management, which would comprehend QoL as an
outcome measure (Table 1: number 12). Unfortunately these
studies failed do conﬁrm beneﬁts of the examined interven-
tions [37].
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given by the closest family of the patient, provided a topic for
just one systematic review, containing 11 observational
studies. The review conﬁrmed importance of the social
support in the early and in late post-stroke period but the
existing doubts were not clariﬁed, related to signiﬁcance of
sources of the support, its types and mechanisms of action
[38]. The authors appeal for further studies, with participation
of greater groups of patients, for standardisation of methods in
measurement of social support and for application of tools
which would allow for simultaneous evaluation of the level,
type and source of social support.
3.3. Burden and quality of life in caregivers of post-stroke
patients
Sequels of stroke are not restricted to the patient, they also
affect his/her family or other close persons who take over the
care of the patient after his/her discharge from the hospital.
The caregivers play an important role in a loved one's recovery
from stroke and are expected to care of him/her, to assist in
usual activities, to cooperate in rehabilitation, to provide
emotional support and to motivate the patient in his/her
recovery. The proportion of patients who stay at home
following the hospital treatment ranges between 80% and
90% while the time devoted to direct care over the patient
ranges from the mean of 5.5–6.4 h a day in Norway and USA to
8.2–9.4 h a day in Poland [39]. The sequels linked to long-term
care are measured by assessment of caregiver burden or strain
and by evaluation of caregivers' QoL. The latter can be
appraised independently of the evaluation of patient's QoL
or in parallel, in caregiver/patient pairs, due to the context of
occasionally complex interpersonal relations [40,41]. The most
frequently applied tools of evaluation include Caregiver Strain
Index (CSI) according to Robinson et al. (1983), Zarit Burden
Interview (ZBI), according to Zarit et al. (1980) and SF-36 or SF-
12 according to Ware et al. (1932) [42,43].
Studies performed in the second half of 1990s and at the
beginning of 2000s, mostly cross-sectional observations,
demonstrated that a signiﬁcant burden affected 25% to around
50% of carers within a period of 1 month to 1–2 years after
stroke [44]. The studies showed also that QoL of caregivers,
evaluated in various domains was, depending on the domain,
similar or signiﬁcantly lower than the comparable in demo-
graphic characteristics populations [45,46]. These observa-
tions were conﬁrmed in recent reports, including the
mentioned above ARCOS studies (New Zealand) [41,47,48]. In
the ARCOS research it was revealed in addition that within the
ﬁrst 6 months of caregiving unfavourable changes in the QoL
developed in over 50% of carers. They were manifested in
reduction of time for the family and social activities, in
exhaustion, and deteriorated emotional well-being. Almost
60% of the caregivers reported that life in general had changed
for the worse.
In contrast to the studies on QoL in patients, few
prospective longer-term observations are available related to
carers, although recently a protocol was published of just
started multi-centre cohort investigations (Restore4Stroke),
with four-fold repeated follow-up assessments in the time
after stroke occurrence. The ﬁrst results of this study can beexpected in two years [49]. The available till now prospective
investigations indicate that in the period between 6th and 18th
month and between the 1st and the 2nd year following stroke
no signiﬁcant alterations in caregivers' quality of life and
burden were noticed [45]. Therefore, it can be concluded that
the deterioration takes place during the ﬁrst months after
stroke and thereafter the caregiver burden and QoL persist at a
relatively stable level.
The main factors which determine post-stroke negative
sequels experienced by the unpaid caregivers include post-
stroke neurological and functional deﬁcit, stroke-linked
behavioural, emotional, cognitive disturbances in patients,
and depression and inadequate or lack of social support in
caregivers [50]. The factors which amplify the unfavourable
effects of stroke include also insufﬁcient knowledge and
competences in provision of care to a person with neurological
impairment as well as difﬁculties in coping with everyday
problems linked to the care. In view of the above the need is
postulated for professional systemic support, dedicated to
caregivers [51].
To support the caregivers different types of training,
counselling and psychoeducational programmes have been
proposed. Their efﬁcacy was evaluated in RCTs, summed up in
systematic reviews. The data synthesis indicate that, apart
from certain advantages, e.g. an increased knowledge on
stroke and improvement in mood, no signiﬁcant evidence was
obtained for the effectiveness of non-pharmacological inter-
ventions in reducing caregiver burden or improving QoL
[52,53]. This failure was partially caused by methodological,
clinical and statistical heterogeneity of the trials. Therefore,
the need is accentuated for continuing studies based on a more
rigorous protocols. Also it has been postulated that more RCTs
of multifaceted programmes, focused on problem-solving
training, during the transitions from hospital to home care,
are needed [52,54,55].
The experienced till now inability to obtain scientiﬁc proofs
for efﬁcacy of interventions targeted at reduction of negative
stroke sequels for the caregivers cannot be considered as
denying need and sense for developing supportive educational
activities, which provide the carers with capabilities and
knowledge, allowing to cope with challenges resulting from
care over post-stroke patients [54]. To balance the body of
knowledge on the negative consequences of long-term
caregiving, studies on positive outcomes have begun to
appear. They found that family caregivers may experience
satisfaction, personal growth and inner strength when they
are actively involved in the care of the family member [56].
4. Summary
Despite the progress in diagnosis, treatment and care
management, stroke remains to create a great health problem
both from the macro perspective and from an individual
patient's and his/her family point of view. Evidence for the
above is provided by objective indices documenting increase in
absolute number of stroke survivors and the linked to this
increase in number of patients with disabilities and requiring
assistance of other persons. Subjective indices, as reported by
the patients indicate that health related QoL after stroke
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in a signiﬁcant proportion of informal caregivers quality of life
becomes deteriorated. Between 25% and 50% of family carers
experience a signiﬁcant burden, which in turn may lead to
subsequent unfavourable health consequences and to the
break-down of the care and institutionalisation of the patients
[54]. Therefore, a number of different types of professional
intervention have been suggested for the patients and their
caregivers, aimed at alleviating the negative consequences of
stroke and at supporting the caregivers in their role. However,
the scientiﬁc evidence related to their efﬁcacy still remains
insufﬁcient and further investigative effort is required both to
improve quality of the research and to optimise the interven-
tions.
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